These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2910245)

  • 21. Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.
    Chevallier B; Heintzmann F; Mosseri V; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M; Asselain B
    Cancer; 1988 Dec; 62(12):2517-24. PubMed ID: 3191451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between hormone receptors in human breast cancer and nuclear grade].
    Nishi T; Okajima K; Fujiwara A; Sekimoto T; Kurokawa A
    Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2172-8. PubMed ID: 6530584
    [No Abstract]   [Full Text] [Related]  

  • 23. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
    Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
    Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body mass index influences palpability but not stage of breast cancer at diagnosis.
    Chagpar AB; McMasters KM; Saul J; Nurko J; Martin RC; Scoggins CR; Edwards MJ
    Am Surg; 2007 Jun; 73(6):555-60; discussion 560. PubMed ID: 17658091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
    Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
    Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
    Macías A; Pascual MR; Pérez R; Lage A
    Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate-specific antigen value as a marker in breast cancer.
    Narita D; Cimpean AM; Anghel A; Raica M
    Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis.
    Molino A; Turazza M; Bonetti A; Biondani P; Griso C; Adami L; Corgnati A; Nortilli R; Pollini GP; Modena S
    Oncology; 1992; 49(2):82-8. PubMed ID: 1574256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic value of estrogen and progesterone receptors in the operable breast cancer: results of a uni- and multifactorial analysis].
    Chevallier B; Heintzman F; Asselain B; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M
    Bull Cancer; 1988; 75(1):23-36. PubMed ID: 3359056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of relapse and survival in breast cancer patients by pS2 protein status.
    Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P
    Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relation of steroid hormone receptors to axillary lymph node metastasis in breast carcinoma].
    Etzrodt A; Jung H; Schweissfurth C; Tolxdorff T; Lamberti G
    Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):726-31. PubMed ID: 6559147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome.
    Joshi MG; Lee AK; Loda M; Camus MG; Pedersen C; Heatley GJ; Hughes KS
    Cancer; 1996 Feb; 77(3):490-8. PubMed ID: 8630956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen and progesterone receptors in human breast cancer.
    Chen TJ; Chen KM
    Taiwan Yi Xue Hui Za Zhi; 1987 Apr; 86(4):366-72. PubMed ID: 3598547
    [No Abstract]   [Full Text] [Related]  

  • 37. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.
    Clark GM; Osborne CK; McGuire WL
    J Clin Oncol; 1984 Oct; 2(10):1102-9. PubMed ID: 6491696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
    Göhring UJ; Ahr A; Scharl A; Weisner V; Neuhaus W; Crombach G; Holt JA
    J Soc Gynecol Investig; 1995; 2(4):653-9. PubMed ID: 9420872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
    Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
    BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of steroid hormones on the growth fraction of human breast carcinomas.
    Jones B; Russo J
    Am J Clin Pathol; 1987 Aug; 88(2):132-8. PubMed ID: 3618547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.